Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Cell Cycle Proteins
  • Drug Delivery Systems
  • Gene Dosage
  • Microtubule-Associated Proteins
  • Nuclear Proteins
  • Pancreatic Neoplasms
  • Up-Regulation

abstract

  • Our results suggest that TPX2 might be an attractive target for pancreatic cancer therapy.

publication date

  • November 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2783218

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-09-0077

PubMed ID

  • 19861455

Additional Document Info

start page

  • 6519

end page

  • 28

volume

  • 15

number

  • 21